Skip to content

Post-Operative Radiotherapy for Selected High Risk Rectal Adenocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN91411631
Enrollment
Unknown
Registered
2002-08-19
Start date
2000-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer Cancer Colorectal

Interventions

Following surgery patients are randomised to one of two treatment arms: 1. Arm A: Post-operative radiotherapy, a midplane dose of 45 Gy given over 4 to 5 weeks 2. Arm B: No radiotherapy

Sponsors

Northern and Yorkshire Clinical Trials and Research Unit (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Histologically proven adenocarcinoma of the rectum 2. Surgery at or below pelvic brim 3. Curative operation, all macroscopic disease removed 4. Aged <80 years, 75 years if physically unfit 5. No previous history of multiple abdominal or pelvic surgical procedures 6. No evidence of small bowel descending into area of maximum dose of radiotherapy 7. Adequate bone marrow function

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026